2023 SNO Pediatric Neuro-Oncology Research Conference
*The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Click Register/Take Course to Claim Credit
*Please log in using the SNO account created during Registration.
*The Access Code can be found in the Post Conference Email.
For technical assistance with claiming CME credit, please email email@example.com .
2023 Pediatric Neuro-Oncology Research Conference
June 22-24, 2023
Capital Hilton, Washington DC
The SNO 7th Biennial Pediatric Neuro-Oncology Research Conference will be held June 22-24, 2023, in Washington, D.C. at the Capital Hilton.
Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. The scientific program will offer outstanding keynotes, panel discussions and abstract presentations on a range of timely themes shaping the future of pediatric neuro-oncology. Topics the conference will address include developmental origins of pediatric brain tumors, novel approaches in cancer neuroscience, artificial intelligence, and machine learning, focused ultrasound/drug delivery, diversity & inclusion, novel immunotherapeutic findings, clinical trial reports, and single cell approaches to decipher molecular landscapes. Conference participants will also have opportunities to present their work — and to learn about advances made by others — through short oral presentations and scientific posters selected by the abstract review committee.
Pediatric neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, physician/scientists, clinical and laboratory trainees, and allied health professionals.
- Define how Artificial Intelligence and machine learning approaches can leverage big genomic data sets in cancer biology towards new discoveries.
- Summarize the interactions between normal cells of the nervous system and cancer cells, and how they drive tumor initiation, progression, and provide new targets for therapy.
- Explain importance of deciphering the developmental origins of pediatric brain tumors, in order to develop future therapeutics and prevention approaches.
Conference Scientific Co-chairs
Dana-Farber Cancer Institute and Boston Children's Hospital
Children's National Hospital
Children's National Hospital
- 18.75 AMA PRA Category 1 Credit™This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Society for Neuro-Oncology. The Society for Neuro-Oncology is accredited by the ACCME to provide continuing medical education for physicians.
- 18.75 Attendance
Instructions to Receive Credit
Click Register/Take Course on the top menu bar to continue to claim credit.
Log in using the email address and password used during the registration process.
Click Register, then Enter the Access Code.
*The access code can be found in the post conference email.
Click Take Course to begin the credit claiming process.
Follow the course instructions to claim credit and receive certificates.